Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluenesulfonate versus propofol for day surgery under general anesthesia
ChiCTR2100047524Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Sedative effectiveness, Respiratory rate and 14 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2100047524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047524.